11 March 2020 - Deborah Wilkes
Archived
Italy’s Angelini Pharma has acquired the global business rights – excluding North America – to GlaxoSmithKline’s (GSK’s) ThermaCare pain-management brand.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.